Drug profile

The FDA adverse-event record for Unknown Brand Lyme Vaccine

10 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unknown Brand Lyme Vaccine. See the species affected, top reactions, and outcomes below.

10
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
7
Lack of efficacy (bacteria) - Borrelia - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Unknown Brand Lyme Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 10

Most Affected Breeds

Collie - Border 2
Shepherd Dog - German 1
Terrier - Yorkshire 1
Shepherd Dog - Australian 1
Coonhound - Treeing Walker 1
Collie (unspecified) 1
Bulldog - French 1
Mountain Dog - Bernese 1
Dachshund - Miniature 1

Most Reported Reactions

Lack of efficacy (bacteria) - Borrelia 7
Lack of efficacy (ectoparasite) - tick NOS 4
Lack of efficacy (bacteria) - NOS 2
Drinking a lot 2
Panting 2
Heavy sweating 2
Not himself/herself 2
Hyperactivity 2
Lethargy (see also Central nervous system depression in 'Neurological') 1
Drug dose omission 1
Vomiting 1
Difficulty to rise 1

Outcome Breakdown

Outcome Unknown
5 (50.0%)
Ongoing
5 (50.0%)

Unknown Brand Lyme Vaccine Adverse Event Insights

10 reports name Unknown Brand Lyme Vaccine; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Unknown Brand Lyme Vaccine. Administration routes: Unknown, Subcutaneous.

By species: Dog (10 reports). By breed: Collie - Border (2), Shepherd Dog - German (1), Terrier - Yorkshire (1).

Leading clinical signs: Lack of efficacy (bacteria) - Borrelia (7), Lack of efficacy (ectoparasite) - tick NOS (4), Lack of efficacy (bacteria) - NOS (2), Drinking a lot (2). Outcome, 10 coded reports: Outcome Unknown leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.